|
Presented at the quarterly NIDA Directors' Report, January 23, 2009.
Betty Tai, PhD, Harold I. Perl, PhD, Carmen L. Rosa, MS, Carol Cushing, RN, Petra Jacobs, MD (all from the Center for the Clinical Trials Network).
This presentation, delivered at the first NIDA Directors' Report quarterly meeting of 2009, showcases some of the "hot science" (published papers) derived from the CTN. It features a discussion of four papers from 2008. The first, an ancillary study of 35 therapists involved in CTN-0004, looks at community program treatment adherence and competence in motivational enhancement therapy (CTN Dissemination Library item 289). The second focuses on measurement and data analysis in research addressing health disparities in substance abuse. This article describes concrete strategies for conducting substance abuse research with ethnic minorities (item 273). Discussed third is an article about the use of standardized patient "walk-throughs" in CTN-0030 to improve the implementation of the protocol (item 272). And finally, a paper featuring the outcomes of CTN-0010, which examined extended vs. short-term buprenorphine/naloxone for treatment of opioid-addicted youth, is described (item 328). (Presentation, PowerPoint slides, English, 2009)
 Keywords: Adolescents | Behavior therapy | Buprenorphine/Naloxone | Community health services | Counselors | Minority groups | Motivational Enhancement Therapy (MET) | National Drug Abuse Treatment Clinical Trials Network | Opioid dependence | Standardized patients (SPs) | Suboxone
Document No: 342
Submitted by Betty Tai, Director, CCTN, 1/28/2009 |
